A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
NATIONAL HEALTH INVESTORS INC
NHI
$3.8B
Mkt Cap
$80.54
+0.74%
NATIONAL HEALTH INVESTORS INC (NHI) has a current P/E ratio of 26.7, compared to its historical median P/E of 15.9. The stock is currently considered Expensive based on its historical valuation range.
NATIONAL HEALTH INVESTORS INC (NHI) has a 5-year average return on invested capital (ROIC) of 10.2%. This indicates solid capital allocation.
NATIONAL HEALTH INVESTORS INC (NHI) has a market capitalization of $3.9B. It is classified as a mid-cap stock.
Yes, NATIONAL HEALTH INVESTORS INC (NHI) pays a dividend with a trailing twelve-month yield of 4.45%.
Based on historical P/E analysis, NATIONAL HEALTH INVESTORS INC (NHI) appears expensive. The current P/E of 26.7 is 68% above its historical median of 15.9. The estimated fair value CAGR (P/E method) is -5.1%.
NATIONAL HEALTH INVESTORS INC (NHI) operates in the Real Estate Investment Trusts industry, within the Real Estate sector.
NATIONAL HEALTH INVESTORS INC (NHI) reported annual revenue of $376 million in its most recent fiscal year, based on SEC EDGAR filings.
Summary Risk Factors Our business is subject to significant risks and uncertainties that make an investment in us speculative and risky. We provide a summary below of what we believe are our principal risk factors, but these risks are not the only ones we face, and you should carefully review and consider the full discussion of our risk factors in “Part I, Item 1A. Risk Factors” in this Annual Report, together with the other information in this Annual Report. If any of the following risks, or any other risks and uncertainties that are not addressed below or elsewhere in this Annual Report or that we have not yet identified, actually occur, our business, financial condition and results of operations could be materially adversely affected, and the value of our securities could decline.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 401M | 376M | 335M | 320M | 278M | 299M |
| Net Income | 148M | 142M | 138M | 136M | 66M | 112M |
| EPS | $3.14 | $3.02 | $3.13 | $3.13 | $1.48 | $2.44 |
| Free Cash Flow | -85M | -57M | 50M | 135M | 174M | 161M |
| ROIC | 0.0% | 10.7% | 12.6% | 12.4% | 6.3% | 9.0% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.20 | 0.36 | 0.24 | 0.20 | 0.31 | 0.26 |
| Dividends/Share | $3.58 | $3.64 | $3.60 | $3.60 | $3.60 | $3.80 |
| Operating Income | 0 | 199M | 198M | 194M | 111M | 163M |
| Operating Margin | 0.0% | 53.1% | 59.0% | 60.6% | 40.0% | 54.4% |
| ROE | 9.8% | 9.8% | 10.5% | 10.7% | 4.8% | 7.4% |
| Shares Outstanding | 48M | 47M | 44M | 43M | 45M | 46M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 178M | 229M | 248M | 279M | 295M | 318M | 333M | 299M | 278M | 320M | 335M | 376M | 401M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 9.1M | 11M | 9.8M | 12M | 13M | 13M | 13M | 18M | 23M | 19M | 21M | 27M | 28M |
| EBIT | 103M | 150M | 196M | 206M | 204M | 217M | 238M | 163M | 111M | 194M | 198M | 199M | 0 |
| Op. Margin | 58.1% | 65.7% | 78.7% | 73.9% | 69.1% | 68.1% | 71.5% | 54.4% | 40.0% | 60.6% | 59.0% | 53.1% | 0.0% |
| Net Income | 102M | 149M | 152M | 159M | 154M | 160M | 185M | 112M | 66M | 136M | 138M | 142M | 148M |
| Net Margin | 57.2% | 65.0% | 61.0% | 57.2% | 52.4% | 50.4% | 55.6% | 37.4% | 23.9% | 42.4% | 41.1% | 37.8% | 36.8% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 6.4M | 52M | 22M | 1.2M | 6.3M | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 7.6% | 10.6% | 10.8% | 9.6% | 12.5% | 13.3% | 13.4% | 9.0% | 6.3% | 12.4% | 12.6% | 10.7% | 0.0% |
| ROE | 11.2% | 13.7% | 12.9% | 12.6% | 11.4% | 11.1% | 12.3% | 7.4% | 4.8% | 10.7% | 10.5% | 9.8% | 9.8% |
| ROA | 5.9% | 7.2% | 6.7% | 6.4% | 5.8% | 5.5% | 6.0% | 3.8% | 2.5% | 5.4% | 5.4% | 5.2% | 5.1% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 126M | 164M | 177M | 198M | 208M | 241M | 232M | 211M | 185M | 184M | 208M | 237M | 244M |
| Free Cash Flow | -407M | 40M | -218M | 22M | 60M | 3.8M | 115M | 161M | 174M | 135M | 50M | -57M | -85M |
| Owner Earnings | 86M | 109M | 116M | 128M | 135M | 163M | 146M | 122M | 106M | 110M | 131M | 150M | -666M |
| CapEx | 533M | 124M | 395M | 176M | 148M | 237M | 117M | 50M | 11M | 50M | 158M | 294M | 329M |
| Maint. CapEx | 38M | 53M | 60M | 67M | 71M | 77M | 83M | 81M | 71M | 70M | 71M | 81M | 904M |
| Growth CapEx | 495M | 71M | 335M | 109M | 76M | 160M | 34M | 0 | 0 | 0 | 86M | 213M | 0 |
| D&A | 38M | 53M | 60M | 67M | 71M | 77M | 83M | 81M | 71M | 70M | 71M | 81M | 904M |
| CapEx/OCF | 422.7% | 75.5% | 223.5% | 88.7% | 71.0% | 98.4% | 50.3% | 23.9% | 5.9% | 20.6% | 66.5% | 115.9% | 135.1% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 101M | 125M | 138M | 153M | 165M | 180M | 195M | 183M | 162M | 156M | 157M | 170M | 173M |
| Dividend Yield | 9.3% | 9.4% | 8.7% | 8.1% | 8.5% | 7.6% | 9.5% | 8.1% | 7.7% | 7.9% | 5.6% | 5.0% | 4.4% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 152M | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 7.8% | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 2.0M | 2.1M | 1.1M | 2.6M | 1.8M | 1.6M | 2.7M | 8.4M | 8.6M | 4.6M | 5.8M | 5.6M | 4.8M |
| Debt Repayment | 329M | 742K | 767K | 251M | 1.1M | 1.2M | 44M | 293M | 135M | 415M | 75M | 201M | 201M |
| Balance Sheet | |||||||||||||
| Net Debt | 684M | -7.8M | 1.3B | 469M | 80M | 295M | 255M | 359M | 381M | 223M | 307M | 531M | 284M |
| Cash & Equiv. | 3.1M | 13M | 4.6M | 3.1M | 4.7M | 5.2M | 43M | 37M | 19M | 22M | 24M | 20M | 25M |
| Long-Term Debt | 329M | 742K | 1.1B | 251M | 1.1M | 0 | 0 | 397M | 0 | 0 | 0 | 346M | N/A |
| Debt/Equity | 0.68 | 0.07 | 1.07 | 0.36 | 0.06 | 0.20 | 0.20 | 0.26 | 0.31 | 0.20 | 0.24 | 0.36 | 0.20 |
| Interest Coverage | 3.9 | 4.0 | 4.5 | 4.4 | 4.1 | 3.9 | 4.5 | 3.2 | 2.5 | 3.3 | 3.3 | 3.5 | 3.5 |
| Equity | 1.0B | 1.1B | 1.2B | 1.3B | 1.4B | 1.5B | 1.5B | 1.5B | 1.3B | 1.3B | 1.4B | 1.5B | 1.5B |
| Total Assets | 2.0B | 2.1B | 2.4B | 2.5B | 2.8B | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 2.6B | 2.8B | 2.9B |
| Total Liabilities | 933M | 991M | 1.2B | 1.2B | 1.4B | 1.5B | 1.6B | 1.3B | 1.2B | 1.2B | 1.2B | 1.3B | 1.4B |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | 20M | 30M | N/A | N/A | N/A | N/A | N/A | 2.3B | 2.5B | 2.6B | 2.7B | 2.8B |
| Working Capital | -4.2M | -8.3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Assets | 11M | 12M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Liabilities | 16M | 20M | 21M | 16M | 20M | 26M | 25M | 23M | 26M | 34M | 38M | 44M | 38M |
| Per Share Data | |||||||||||||
| EPS | 3.04 | 3.95 | 3.87 | 3.87 | 3.67 | 3.67 | 4.14 | 2.44 | 1.48 | 3.13 | 3.13 | 3.02 | 3.14 |
| Owner EPS | 2.57 | 2.90 | 2.96 | 3.12 | 3.20 | 3.72 | 3.27 | 2.65 | 2.36 | 2.54 | 2.96 | 3.19 | -13.78 |
| Book Value | 31.11 | 30.07 | 30.89 | 32.11 | 33.05 | 34.25 | 33.82 | 32.89 | 28.31 | 28.95 | 31.02 | 32.37 | 31.36 |
| Cash Flow/Share | 3.77 | 4.36 | 4.51 | 4.81 | 4.94 | 5.51 | 5.19 | 4.60 | 4.13 | 4.26 | 4.72 | 5.03 | 21.78 |
| Dividends/Share | 3.08 | 3.40 | 3.60 | 3.80 | 4.00 | 4.20 | 4.41 | 3.80 | 3.60 | 3.60 | 3.60 | 3.64 | 3.58 |
| Shares Out. | 33.4M | 37.7M | 39.2M | 41.2M | 42.1M | 43.7M | 44.7M | 45.8M | 44.9M | 43.3M | 44.0M | 47.0M | 48.3M |
| Valuation | |||||||||||||
| P/E Ratio | 12.2 | 8.8 | 11.0 | 12.2 | 13.5 | 15.4 | 12.6 | 18.4 | 29.5 | 16.4 | 20.7 | 25.2 | 25.6 |
| P/FCF | N/A | 32.4 | N/A | 87.0 | 34.7 | 654.3 | 20.2 | 12.8 | 11.2 | 16.5 | 57.2 | N/A | N/A |
| EV/EBIT | 18.7 | 8.6 | 82.0 | 238.8 | 10.6 | 12.7 | 10.9 | 14.8 | 21.0 | 17.1 | 20.0 | 23.6 | N/A |
| Price/Book | 1.2 | 1.2 | 1.4 | 1.5 | 1.5 | 1.6 | 1.5 | 1.4 | 1.5 | 1.8 | 2.1 | 2.4 | 2.6 |
| Price/Sales | 6.1 | 5.8 | 6.4 | 6.8 | 6.6 | 7.4 | 6.1 | 7.5 | 7.6 | 6.2 | 8.3 | 9.0 | 9.7 |
| FCF Yield | -32.8% | 3.1% | -13.0% | 1.1% | 2.9% | 0.2% | 4.9% | 7.8% | 8.9% | 6.1% | 1.7% | -1.6% | -2.2% |
| Market Cap | 1.2B | 1.3B | 1.7B | 1.9B | 2.1B | 2.5B | 2.3B | 2.1B | 2.0B | 2.2B | 2.9B | 3.6B | 3.9B |
| Avg. Price | 32.24 | 35.24 | 40.71 | 46.01 | 46.32 | 53.81 | 45.71 | 49.08 | 47.02 | 45.79 | 63.38 | 71.65 | 80.54 |
| Year-End Price | 37.10 | 34.66 | 42.72 | 47.11 | 49.63 | 56.41 | 52.19 | 44.81 | 43.64 | 51.27 | 64.71 | 76.22 | 80.54 |
NATIONAL HEALTH INVESTORS INC passes 3 of 9 quality checks, indicating weak fundamentals.
NATIONAL HEALTH INVESTORS INC trades at 26.7x trailing earnings, compared to its 15-year median P/E of 15.9x, suggesting it is currently Expensive relative to its historical range. The company's 5-year average ROIC is 10.2%. Total shareholder yield (dividends) is 4.4%. At current prices, the estimated annualized return to fair value is +20.3%.
NATIONAL HEALTH INVESTORS INC (NHI) has a net profit margin of 37.8%. This is a strong margin indicating high profitability.
NATIONAL HEALTH INVESTORS INC (NHI) generated $-57 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
NATIONAL HEALTH INVESTORS INC (NHI) has a debt-to-equity ratio of 0.36. This indicates a conservatively financed balance sheet.
NATIONAL HEALTH INVESTORS INC (NHI) reported earnings per share (EPS) of $3.02 in its most recent fiscal year.
NATIONAL HEALTH INVESTORS INC (NHI) has a return on equity (ROE) of 9.8%. This indicates moderate shareholder returns.
The Ledger Terminal provides 18 years of financial data for NATIONAL HEALTH INVESTORS INC (NHI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NATIONAL HEALTH INVESTORS INC (NHI) has a book value per share of $32.37, based on its most recent annual SEC filing.